Predictive Oncology Investor Relations Material

Predictive Oncology Inc. is a biotechnology company focused on using artificial intelligence (AI) and data-driven solutions to advance personalized cancer treatments. The company leverages its proprietary AI platform and extensive biobank of tumor samples to develop predictive models that assist in identifying the most effective therapies for individual cancer patients. Predictive Oncology's services cater to the pharmaceutical, biotechnology, and research industries, providing valuable insights for drug discovery and development. The company is headquartered in Eagan, Minnesota, and its shares are listed on the NASDAQ.